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Abstract We set out to present potency results after bilat-
eral, unilateral, and semi-sparing of the neurovascular bun-
dles after robotic prostatectomy. Two hundred and twenty-
Wve consecutive robotic-assisted laparoscopic radical pros-
tatectomies were performed by one surgeon (NPW) from
the start of our robotic program in January 2002 until
December 2005. Patient demographics, operative, and post-
operative data were prospectively entered into a database.
We have functional data for 183, 150, and 109 patients fol-
lowed for 3, 6, and 12 months, respectively. Of 49 preoper-
atively potent patients 36 (73%, 95% CI 59–85%) had
erections suYcient for intercourse at 12 month follow-up.
If bilateral nerve sparing was performed, 13 (87%, 95% CI
59–85%) of the patients showed a return of potency suY-
cient for intercourse. In preoperatively potent patients who
did not undergo a traditional nerve sparing due to a high-
risk disease, semi-sparing of the neurovascular bundles
showed a return of potency in 10 (53%, 95% CI 29–76%).
After one-year follow-up, 66 of 71 (93%, 95% CI 84–98%)
had no need for protective pads and two (3%) used more
than one pad a day. In the Wrst 100 patients there were 24
(24%) positive surgical margins and for the last 125
patients there were 18 (14%). Based on these data, we
hypothesize that certain subgroups, e.g., men wanting to
preserve their sexual potency but having a tumor that hin-
ders a traditional nerve-sparing approach, may be particu-
larly helped by robot-assisted laparoscopic surgery as
compared with other techniques.
Keywords Laparoscopy · Nerve-sparing · Prostatectomy · 
Potency · Robotics
Introduction
Radical prostatectomy is an eVective treatment for local-
ized prostate cancer, reducing overall and disease-speciWc
mortality [1]. However, the number of men that must be
treated to prevent one death from prostate cancer is high. A
randomized trial found no impact on the average level of
self-assessed quality of life after four years of follow-up
[2]. Urinary leakage and erectile dysfunction occurring as a
consequence of radical prostatectomy reduces quality of
life [3]. So, reducing the percentage of men contracting
erectile dysfunction after radical prostatectomy may
improve self-assessed quality of life for prostate-cancer
survivors.
Robot-assisted laparoscopic prostatectomy has been
claimed to achieve excellent potency outcomes when a
nerve-sparing procedure is performed [4]. Nevertheless a
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tomy where a traditional nerve-sparing procedure cannot be
recommended due to the high-risk tumour and consequent
risk of positive surgical margin.
We present a novel technique of semi-nerve-sparing in
these high-risk patients.
Methods
Between the initiation of our robotic program in January
2002 and December 2005, 225 consecutive patients under-
went robot-assisted laparoscopic radical prostatectomy by a
single surgeon (NPW). The indications for robotic surgery
are identical to open surgery at our institution. The surgeon
had extensive experience of open radical prostatectomy but
lacked laparoscopic experience before commencing with
robotic surgery.
Our surgical technique has been previously described
[5]. Five transperitoneal ports are placed: three for the
robotic system and two for the assisting surgeon. Posterior
dissection of the vasa deferentia and seminal vesicles is
performed. The seminal vesicle tips are spared during full
nerve-sparing procedures to avoid undue trauma to the neu-
rovascular bundles, which may come into proximity with
the lateral tips of the seminal vesicles [6]. The Denonvil-
liers fascia is opened and the plane between the Denonvil-
liers fascia and the perirectal fat is developed. After
mobilizing the urinary bladder, the endopelvic fascia is
incised. A bladder-neck-sparing dissection is thereafter pre-
formed. During nerve-sparing procedures clips are applied
when dividing the vascular pedicles, avoiding any thermal
heat near the neurovascular bundles. When traditional
nerve sparing is planned an interfacial technique is
preferred. In patients with high-volume disease, a semi-
nerve-sparing technique is preformed. Our semi-sparing
technique involves dissection in a plane within the neuro-
vascular bundles that thereby leaves a rim of neurovascular
tissue on the prostatic surface, but leaves a substantial
amount of the neurovascular bundles (NVB) intact in the
patient. Semi-sparing was performed either bilaterally or
unilaterally if traditional nerve sparing was performed on
the contra-lateral side. Clips were applied during dissection
to avoid thermal trauma to the erectile nerves. The dorsal
venous complex was sharply divided and thereafter over-
sewn. Anastomosis was performed with a running suture as
described by Van Velthoven [7].
Operating times and other perioperative parameters were
collected prospectively. Tumor margins and specimen sta-
tus were collected from standard pathology reports. Posi-
tive margin was deWned as tumor cells present at the inked
surface. Focally positive surgical margins were deWned as
3 mm or less of tumor present at the inked surface in one
section, and nonfocal positive margins were deWned as
tumor exceeding 3 mm at the inked surface in one or more
sections. A self-administered questionnaire regarding uri-
nary and potency status was mailed to the patients 3, 6, and
12 months after surgery. After the 46th patient in the series,
questionnaires were also mailed preoperatively.
The patients were asked to complete the questionnaire and
to send it to a research nurse for data collection. The ques-
tionnaire was composed of simple questions asking, e.g., do
you experience urinary leakage and how many protective
pads do you need during an ordinary day? Concerning
potency the question was worded as, when sexually aroused,
were erections suYcient for sexual penetration, with Wve pos-
sible answers ranging from never to always. We deWned
potency as the ability to perform sexual penetration in at least
half of attempts with or without the use of phosphodiesterase
(PDE) inhibitors. Urinary continence was evaluated with the
use of protective pads. Eleven patients did not receive a ques-
tionnaire and we thus cannot asses the functional outcome for
them. The numbers of patients followed for 3, 6, and
12 months were 183, 150, and 109, respectively.
Data was prospectively entered into a database. For preva-
lence, we calculated a 95% conWdence interval (CI) which
was calculated using an augmenting binominal distribution.
Results
Among the 225 patients, the mean age was 61.7 (range 36–
75) years, mean prostate speciWc antigen (PSA) was 7.9
(1.5–21) ng ml¡1, and mean preoperative Gleason score
was 6.2 (4–9). Overall 60.4% were staged as T1, 36.9%
were staged as T2, and 2.7% were staged as having T3 dis-
ease (Table 1). There were 24 (24%) positive surgical mar-
gins in the Wrst 100 patients, 16 of which were extensively
positive and eight of which were focally positive. In the last
125 patients there were 14% positive surgical margins: six
(4.8%) extensively positive and 11 (8.8%) focally positive.
There were nine (10.6%) positive margins in pT2 tumours
Table 1 Baseline characteristics for 225 patients operated with robot-
assisted laparoscopic radical prostatectomy




Mean age, years (range) 61 (36–71) 62.3 (46–75)
Mean PSA, ng ml¡1 (range) 6.5 (0.5–15) 7.4 (1.1–21)
Mean preoperative 
Gleason score (range) 
6 (4–9) 6.3 (5–9)
T1c tumours (%) 64 (64%) 71 (56.8%)
T2 tumours (%) 31 (31%) 53 (42.4%)
T3 tumours (%) 5 (5%) 1 (0.8%)
Volume, ml (range) 36.6 (15.5–90) 45.9 (14–177)123
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125 cases (Table 2).
With potency deWned as erections suYcient for penetra-
tion in at least half of attempts, 84 patients out of 168 were
deWned as preoperatively potent. When bilateral nerve spar-
ing was attempted, 19 (52.8%), 15 (57.7%), and 13 (86.7%)
patients had return of potency after 3, 6, and 12 months,
respectively. In men who were unilaterally nerve spared the
Wgures were eight (32%), 11 (44%), and 13 (86.7%)
patients with a return to potency after 3, 6, and 12 months,
respectively. In preoperatively potent patients who under-
went semi-sparing of both neurovascular bundles, due to an
advanced tumour, four (17.4%), four (20%) and 10 (52.6%)
had a return to potency at 3, 6, and 12 months, respectively
(Table 3, 4).
Three months after surgery 90 (66.2%) of the patients
reported that they did not need protective pads for urinary
leakage, 29 (21.3%) reported the use of one pad per day,
and 17 (12.5%) needed more than one pad. At 6 months
follow-up 114 (85.1%) reported no use of protective pads,
13 (9.7%) needed pads for security reasons, and seven
(5.2%) needed to change pads. Twelve months after sur-
gery 66 (93%) reported no need for protective pads and
three (4.3%) used one pad per day (Table 5).
Table 2 Pathology for 225 
patients operated with robot-
assisted laparoscopic radical 
prostatectomy




pT2 tumours 64 (64) 85 (68)
pT3 tumours 36 (36) 40 (32)
Extensive positive margins 16 (16) 7 (5.6)
Focal positive margins 8 (8) 11 (8.8)
Positive margins in pT2 tumours 11 (17.2) 9 (10.6)
Positive margins in pT3 tumours 13 (36.1) 9 (22.5)
Table 3 Potency data 3, 6, and 12 months after robot-assisted laparoscopic radical prostatectomy




spared, no./tot. no. (%)
Unilaterally nerve 
spared, no./tot. no. (%)




3 months 19/36 (52.8) 8/24 (33.3) 4/23 (17.4) 92.4
6 months 15/26 (57.7) 11/24 (45.8) 4/20 (20) 84.5
12 months 13/15(86.7) 13/15 (86.7) 10/19 (52.6) 95.8
Table 4 Oncological data for 








Age (range) 59.8 (46–71) 60.4 (53–74) 63.5 (59–72)
PSA ng ml¡1 (range) 6.6 (2.7–21) 6.6 (1.1–14) 8.5 (3.2–17)
T1c tumours (%) 30/36 (83.3%) 11/24 (45.8%) 10/23 (43.5%)
T2 tumours (%) 6/36 (16.6%) 13/24 (54.2%) 11/23 (47.8%)
T3 tumours (%) 0/36 0/24 2/23 (8.7%)
Gleason score (preoperatively) · 6 32/36 (88.9%) 19/24 (79.2%) 16/23 (69.6%)
= 7 4/36 (11.1) 3/24 (12.5%) 6/23 (26.1%)
¸ 8 0/36 2/24 (8.3%) 1/23 (4.4%)
pT3 tumours (%) 7/36 (24.1%) 5/24 (20.8%) 13/23 (56.5%)
Positive margins (%) 7/36 (24.1%) 4/24 (16.7%) 4/23 (15.7%)
Table 5 Continence data after 
3, 6, and 12 mounts after robot-












3  90 (66.2) 29 (21.3) 17 (12.5) 74.3
6  114 (85.1) 13 (9.7) 7 (5.2) 81.2
12  66 (93) 3 (4.3) 2 (2.7) 65.1123
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and the mean estimated blood loss was 158 (50–1,200) ml.
One patient required conversion to an open procedure (case
number 9) due to lack of progress. Two patients developed
strictures in the anastomosis, necessitating dilation. Seven
major complications occurred in the series. Four patients
were taken back to the operating room, due to postoperative
haemorrhage in two and catheter problems in two. A ure-
teral injury occurred in the Wrst case of the series, requiring
subsequent open ureteral reimplantation. One patient
needed bilateral percutaneous nephrostomy due to an anas-
tomotic leakage. One patient experienced temporary femo-
ral nerve palsy.
Discussion
Strictly it is impossible to draw any conclusions from this
single-surgeon series without a concurrent comparison
group concerning oncological and functional outcomes.
Robotic prostatectomy, as performed in this study, resulted
in the preservation of potency in the majority (73%) of pre-
operatively potent patients at 1 year follow-up, irrespective
of whether traditional nerve-sparing or a semi-sparing
approach was performed. A return to potency was seen in
87, 87, and 53% in the bilaterally nerve-spared, unilaterally
nerve-spared, and semi-spared groups, respectively.
We were encouraged by Wnding that 10 out of 19 men
classiWed as sexually potent before surgery, and in whom
the surgeon did not try to extensively preserve either of the
two neurovascular bundles, had preserved sexual potency
one year postoperatively. One can speculate that the
enhanced visualization of the anatomical structures with
the robotic system admits semi-sparing of the neurovascu-
lar bundles in the subset of patients with a high-risk dis-
ease, where traditional nerve sparing is usually not
preformed because of the high risk of positive margins. If
the dissection is kept in a plane within the neurovascular
bundles and if the surgeon avoids thermal trauma by dia-
thermy, preservation of the erectile function may be
achieved without an increased incidence of positive surgi-
cal margins in this subset of high-risk patients. It has pre-
viously been reported that a return to potency occur in a
majority of patients when traditional nerve-sparing,
whether bilateral or unilateral, is performed, but to our
knowledge this has not been reported when traditional
nerve sparing has not been performed even though a return
to potency in up to 38% of the non-nerve-spared patients is
seen after open surgery [8, 9]. So, based on the data from
the 19 men in this series, we hypothesise that robot-
assisted laparoscopic surgery is particularly beneWcial for
men giving full priority to optimal survival length over
avoiding therapy-induced erectile dysfunction, but who
nevertheless would have a better quality of life with pre-
served erectile function. Of course we need more data than
from this small group before we can judge whether or not
semi-sparing of nerve bundles can be done with intact
function one year later.
There are numerous reports with excellent potency out-
comes after open and minimal invasive surgery [9, 10, 11].
Menon reports a 97% potency rate after a nerve-sparing
robotic procedure, of which 71% had recovered normal
erectile function one year after surgery [4]. Walsh reported
a potency rate of 86% 18 months after nerve-sparing retrop-
ubic radical prostatectomy, and Catalona reported a 76%
potency rate after bilateral nerve sparing in 1,770 patients
[12, 13]. Montorsi reports a 52% potency rate after only
six months follow-up [14]. All men in these series were
operated by a single high-proWle surgeon at a high-volume
institution. However, the results may reXect the capacity of
the surgical technique involved.
Quality-of-life studies after radical prostatectomy show
less encouraging results when including non-nerve-sparing
procedures. Historical data from Sweden, including both
nerve-spared and non-nerve-spared patients, show a
potency rate of 20% four years after surgery [2]. Data from
CaPSURE show that only 20% reach baseline potency one
year after surgery [15]. Theoretically it seems that much
can be gained if nerve sparing or semi-sparing could be
performed in all preoperatively potent patients that choose
radical prostatectomy.
We present all consecutive patients operated by one sur-
geon with no previous laparoscopic experience with a novel
technique. There is inevitably a learning-curve eVect to be
overcome, even though reports have shown a shorter learn-
ing curve for robot-assisted laparoscopic radical prostatec-
tomy compared with standard laparoscopy [16–19]. We
therefore anticipate that increasing experience with the pro-
cedure will translate into further improvements in oncolog-
ical and functional outcome.
We hypothesize that certain subgroups, e.g., men with a
tumor, which precludes saving the neurovascular bundles in
extenso, and wanting to maintain erectile function, are par-
ticularly helped by robotic instead of open surgery.
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